Table 3 Number of patients in the diagnostic groups (IIM: idiopathic inflammatory myopathy; other IRD: inflammatory rheumatic disease other than IIM; no IRD: no inflammatory rheumatic disease; ASS: anti-synthetase syndrome; DM: dermatomyositis; PM: polymyositis; OM: overlap-myositis; SSc: systemic sclerosis; SLE: systemic lupus erythematosus; UCTD: undifferentiated connective tissue disease; RA: rheumatoid arthritis; SPA: spondyloarthritis; other: giant cell arteritis; cryoglobulinemic vasculitis, behçet’s disease; microscopic polyangiitis; primary sjögren syndrome; mixed connective tissue disease)
Number of patients in the diagnostic groups, n = 209 (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
IMM, 37 (17.7) | Other IRD, 90 (43.1) | No IRD, 82 (39.2) | ||||||||
DM, 9 (4.3) | PM, 7 (3.3) | ASS, 2 (1.0) | OM, 19 (9.1) | SSc, 5 (2.4) | SLE, 9 (4.3) | UCTD, 25 (12.0) | RA, 32 (15.3) | SPA, 9 (4.3) | Other, 10 (4.8) | No IRD, 82 (39.2) |